NAVIGATION

July 30, 2016

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Queen Conch Research in the Florida Keys
Queen Conch Research in the Florida Keys

FWC’s queen conch research program has been surveying queen conch throughout the Florida Keys since 1987, and they perform yearly surveys in order to determine trends in the recovery of Florida’s queen conch population.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Did the conventions change your mind about the presidential candidates?

  • Yes, what I heard influenced me to make that final decision
  • No, feel same now as before conventions

See Results

Ballot Box
Subscribe